載入...
Design of potent, proteolytically stable oxyntomodulin analogs
Incretin-based peptides are effective therapeutics for treating type 2 diabetes mellitus (T2DM). Oxyntomodulin (OXM), a dual agonist of GLP-1R and GCGR, has shown superior weight loss and glucose lowering effects, compared to single GLP-1R agonists. To overcome the short half-life and rapid renal cl...
Na minha lista:
發表在: | ACS Chem Biol |
---|---|
Main Authors: | , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861236/ https://ncbi.nlm.nih.gov/pubmed/26727558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.5b00787 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|